Please login to the form below

Not currently logged in
Email:
Password:

Parexel appoints CEO

Jamie Macdonald succeeds co-founder Josef von Rickenbach

Jamie MacdonaldBiopharmaceutical services provider, Parexel, has appointed Jamie Macdonald as its chief executive officer (CEO), a role that will see him succeed Josef von Rickenbach.

Macdonald previously led INC Research, now known as Syneos Health, for several years first as CEO and most recently as vice chairman.

He has also served as senior vice president and head of global project management at Quintiles, now IQVIA.

Macdonald said: “As a trail blazer in the biopharmaceutical services industry, the company enjoys well-deserved recognition as having the kind of deep therapeutic and functional expertise, global reach and innovative capability to continue its leadership.

“I am humbled to have the opportunity to build on this legacy and look forward to continued growth and excellence for Parexel.”

20th March 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics